{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T17:27:15Z","timestamp":1786987635703,"version":"build-2736575974"},"reference-count":15,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/j.cyto.2023.156353","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T23:46:11Z","timestamp":1693871171000},"page":"156353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Anti-Interleukin-17s for successful management of pustular psoriasis"],"prefix":"10.1016","volume":"171","author":[{"given":"Prisca","family":"Guerra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elia","family":"Rosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilaria","family":"Scandagli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmarco","family":"Silvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Nunziati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Di Cesare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Prignano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2023.156353_b0005","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1111\/jdv.14949","article-title":"Generalized Pustular Psoriasis: A Review and Update on Treatment","volume":"32","author":"Hoegler","year":"2018","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cyto.2023.156353_b0010","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2147\/PTT.S180608","article-title":"Acrodermatitis Continua of Hallopeau: Clinical Perspectives","volume":"9","author":"Smith","year":"2019","journal-title":"PTT"},{"key":"10.1016\/j.cyto.2023.156353_b0015","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jaad.2021.01.023","article-title":"The Clinical Spectrum of COVID-19\u2013Associated Cutaneous Manifestations: An Italian Multicenter Study of 200 Adult Patients","volume":"84","author":"Marzano","year":"2021","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2023.156353_b0020","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.3390\/jcm10245841","article-title":"Skin Manifestations in Psoriatic and HS Patients in Treatment with Biologicals during the COVID-19 Pandemic","volume":"10","author":"Rosi","year":"2021","journal-title":"J. Clin. Med."},{"issue":"3","key":"10.1016\/j.cyto.2023.156353_b0025","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/bjd.14702","article-title":"Japanese Brodalumab Study Group Efficacy and Safety of Brodalumab in Patients with Generalized Pustular Psoriasis and Psoriatic Erythroderma: Results from a 52-Week, Open-Label Study","volume":"176","author":"Yamasaki","year":"2017","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.cyto.2023.156353_b0030","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/jdv.15287","article-title":"Long-Term Efficacy and Safety of Ixekizumab in Japanese Patients with Erythrodermic or Generalized Pustular Psoriasis: Subgroup Analyses of an Open-Label, Phase 3 Study (UNCOVER-J)","volume":"33","author":"Okubo","year":"2019","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.cyto.2023.156353_b0035","doi-asserted-by":"crossref","DOI":"10.1111\/dth.12899","article-title":"Biologic Therapy for Acrodermatitis Continua of Hallopeau: Successful Treatment with Secukinumab and Review of the Literature","volume":"32","author":"Galluzzo","year":"2019","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.cyto.2023.156353_b0040","doi-asserted-by":"crossref","DOI":"10.1111\/dth.14301","article-title":"Brodalumab in the Treatment of Recalcitrant Acrodermatitis Continua of Hallopeau","volume":"33","author":"Bardazzi","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.cyto.2023.156353_b0045","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.jaad.2019.09.040","article-title":"Real-World Single-Center Experience with 10 Cases of Generalized Pustular Psoriasis Successfully Treated with Ixekizumab","volume":"82","author":"Nagata","year":"2020","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.cyto.2023.156353_b0050","doi-asserted-by":"crossref","first-page":"e13170","DOI":"10.1111\/dth.13170","article-title":"Effectiveness of Brodalumab in Acrodermatitis Continua of Hallopeau: A Case Report","volume":"33","author":"Passante","year":"2020","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.cyto.2023.156353_b0055","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1080\/09546634.2019.1628170","article-title":"Treatment of Acrodermatitis Continua of Hallopeau with Ixekizumab","volume":"32","author":"Miller","year":"2021","journal-title":"J. Dermatol. Treat."},{"key":"10.1016\/j.cyto.2023.156353_b0060","doi-asserted-by":"crossref","first-page":"e15382","DOI":"10.1111\/dth.15382","article-title":"Generalized Pustular Psoriasis Rapidly and Successfully Treated with Ixekizumab in a Caucasian Patient","volume":"35","author":"Megna","year":"2022","journal-title":"Dermatol. Ther."},{"key":"10.1016\/j.cyto.2023.156353_b0065","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1080\/14712598.2022.2116978","article-title":"Targeting IL-17A for the Treatment of Pustular Psoriasis: A Comprehensive Review","volume":"22","author":"Rosi","year":"2022","journal-title":"Expert Opin. Biol. Ther."},{"key":"10.1016\/j.cyto.2023.156353_b0070","first-page":"307","article-title":"\u201cAutoinflammatory Psoriasis\u201d-Genetics and Biology of Pustular Psoriasis","volume":"18","author":"Uppala","year":"2021","journal-title":"CellMol. Immunol."},{"key":"10.1016\/j.cyto.2023.156353_b0075","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40257-021-00658-9","article-title":"Treatment Options and Goals for Patients with Generalized Pustular Psoriasis","volume":"23","author":"Krueger","year":"2022","journal-title":"Am. J. Clin. Dermatol."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466623002314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,9]],"date-time":"2025-01-09T04:58:33Z","timestamp":1736398713000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466623002314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":15,"alternative-id":["S1043466623002314"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156353","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-Interleukin-17s for successful management of pustular psoriasis","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2023.156353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"156353"}}